ICPerMed Conference shows Progression of Personalised Medicine Approaches
Assembling around 300 experts from 32 countries from November 20 to 21 in Berlin as well as 500 viewers online, the first ‘Personalised Medicine in Action’ conference of the International Consortium for Personalised Medicine (ICPerMed) presented best practice examples for successful implementations of personalised medicine approaches in Europe and beyond.
So far outgoing ICPerMed Chair Mairéad O'Driscoll was very pleased with the progression: "The funding of basic research in the broad field of personalised medicine is starting to pay off. Our conference programme showed that today patients already benefit from ground-breaking personalised therapies, e.g. for lung cancer or metabolic diseases".
That personlised medicine still has an outstanding position in the European research agenda and at political level was underlined by the attendance of high-level representatives of the German Federal Ministries for Research & Education and Health, the European Commission (DG RTD & CNECT) and the European Parliament.
Vibeke Andersen from the Institute of Molecular Medicine of the University of Southern Denmark who has already taken part in past ICPerMed events travelled to Berlin representing SYSCID and creating a link to this important initiative.
ICPerMed provides a platform to initiate and support communication and exchange on personalised medicine research, funding and implementation assembling over 40 European and international partners representing ministries, funding agencies and the European Commission. To find out more and to read the entire post conference press release, please follow this link.